In terms of current research progress, CD73 can inhibit the progression of viral hepatitis to a certain extent, promote the formation of fatty liver, delay the progression of steatohepatitis, and promote the progression of liver fibrosis and liver cancer through the adenosine pathway. This evidence concerns the gene NT5E and fatty liver disease.